USA - engelska - NLM (National Library of Medicine)

h.j. harkins company, inc. - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin capsules, ampicillin for oral suspension and other antibacterial drugs, ampicillin capsules and ampicillin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.  when culture and susceptibility information are available, they should be considered in selecting of modifying anitimicrobial therapy, in the absence of such data, local epidemiology and susceptibility patterns contribute to the empiric selection of therapy. ampicillin capsules and ampicillin for oral suspension are indicated in the treatment of infections caused by susceptible strains of the designated organisms listed below: infections of the genitourinary tract including gonorrhea - e. coli, p. mirabilis , enterococci, shigella , s. typhosa and other salmonella and nonpenicillinase-producing n. gonorrhoeae . infections of the respiratory tract - nonpenicillinase-produc

USA - engelska - NLM (National Library of Medicine)

blenheim pharmacal, inc. - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin capsules, ampicillin for oral suspension and other antibacterial drugs, ampicillin capsules and ampicillin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.  when culture and susceptibility information are available, they should be considered in selecting of modifying anitimicrobial therapy, in the absence of such data, local epidemiology and susceptibility patterns contribute to the empiric selection of therapy. ampicillin capsules and ampicillin for oral suspension are indicated in the treatment of infections caused by susceptible strains of the designated organisms listed below: infections of the genitourinary tract including gonorrhea - e. coli, p. mirabilis , enterococci, shigella , s. typhosa and other salmonella and nonpenicillinase-producing n. gonorrhoeae . infections of the resp

USA - engelska - NLM (National Library of Medicine)

mylan institutional llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 10 g in 100 ml - ampicillin for injection, usp is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: respiratory tract infections caused by streptococcus pneumoniae , staphylococcus aureus (penicillinase and nonpenicillinase-producing), h. influenzae , and group a beta-hemolytic streptococci. bacterial meningitis caused by e. coli , group b streptococci, and other gram-negative bacteria (listeria monocytogenes, n. meningitidis ). the addition of an aminoglycoside with ampicillin may increase its effectiveness against gram-negative bacteria. septicemia and endocarditis caused by susceptible gram-positive organisms including streptococcus spp., penicillin g-susceptible staphylococci, and enterococci. gram-negative sepsis caused by e. coli, proteus mirabilis and salmonella spp. responds to ampicillin. endocarditis due to enterococcal strains usually respond to intravenous therapy. the addition of an aminoglycoside may enhance the effectiveness of

Grekland - grekiska - Εθνικός Οργανισμός Φαρμάκων

ΚΟΠΕΡ Α.Ε. ΑΡΙΣΤΟΒΟΥΛΟΥ 64, 11853 Κ. ΠΕΤΡΑΛΩΝΑ 3462102 3462108 - ampicillin sodium - pd.inj.sol (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 1g/vial - ampicillin sodium 1.063mg - ampicillin

USA - engelska - NLM (National Library of Medicine)

fresenius kabi usa, llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin 10 g - indications and usage: ampicillin and sulbactam for injection, usp is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus, escherichia coli,* klebsiella spp.* (including k. pneumoniae *), proteus mirabilis,* bacteroides fragilis,* enterobacter spp.,* and acinetobacter calcoaceticus .* note: for information on use in pediatric patients see precautions, pediatric use and clinical studies sections. intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli, klebsiella spp. (including k. pneumoniae *), bacteroides spp. (including b. fr

Nederländerna - nederländska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

alfasan nederland b.v. - ampicilline natrium - poeder voor oplossing voor injectie - ampicilline natrium 100 mg/ml, - ampicillin - honden; katten

Nederländerna - nederländska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

alfasan nederland b.v. - ampicilline 3-water - tablet - ampicilline 3-water 50 mg/stuk, - ampicillin - honden; katten

Nederländerna - nederländska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

alfasan nederland b.v. - ampicilline 3-water - suspensie voor injectie - ampicilline 3-water 149,4 mg/stuk, - ampicillin - honden; katten

Nederländerna - nederländska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

alfasan nederland b.v. - ampicilline 3-water - suspensie voor injectie - ampicilline 3-water 200 mg/ml, - ampicillin - honden; katten; runderen; varkens

Nederländerna - nederländska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

kepro b.v. - ampicilline 3-water - suspensie voor injectie - ampicilline 3-water 200 mg/ml, - ampicillin - honden